BeiGene, Ltd. - stock earnings
BGNE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -367.6 million USD | 634.4 million USD |
| 2023Q3 | 215.4 million USD | 781.3 million USD |
| 2023Q2 | -381.1 million USD | 595.3 million USD |
| 2023Q1 | -348.4 million USD | 447.8 million USD |
| 2022Q4 | -445.3 million USD | 380.1 million USD |
| 2022Q3 | -557.6 million USD | 387.6 million USD |
| 2022Q2 | -571.4 million USD | 341.6 million USD |
| 2022Q1 | -434.3 million USD | 306.6 million USD |
| 2021Q4 | -585.7 million USD | 214.0 million USD |
| 2021Q3 | -413.9 million USD | 206.4 million USD |
| 2021Q2 | -480.3 million USD | 150.0 million USD |
| 2021Q1 | 66.5 million USD | 605.9 million USD |
| 2020Q4 | -472.7 million USD | 100.1 million USD |
| 2020Q3 | -425.2 million USD | 91.1 million USD |
| 2020Q2 | -335.2 million USD | 65.6 million USD |
| 2020Q1 | -363.7 million USD | 52.1 million USD |
| 2019Q4 | -388.1 million USD | 56.9 million USD |
| 2019Q3 | -307.4 million USD | 50.1 million USD |
| 2019Q2 | -85.6 million USD | 243.3 million USD |
| 2019Q1 | -167.6 million USD | 77.8 million USD |
| 2018Q4 | -268.3 million USD | 58.7 million USD |
| 2018Q3 | -144.0 million USD | 54.2 million USD |
| 2018Q2 | -156.9 million USD | 52.8 million USD |
| 2018Q1 | -104.6 million USD | 32.5 million USD |
| 2017Q4 | -99.3 million USD | 18.2 million USD |
| 2017Q3 | 117.4 million USD | 220.2 million USD |
| 2017Q2 | -60.5 million USD | 2000 USD |
| 2017Q1 | -50.6 million USD | 8000 USD |
| 2016Q4 | -37.6 million USD | 137.1 million USD |
| 2016Q3 | -35.5 million USD | -137000 USD |
| 2016Q2 | -24.1 million USD | 393000 USD |
| 2016Q1 | -22.0 million USD | 677000 USD |
| 2015Q4 | -27.3 million USD | 4.7 million USD |
| 2015Q3 | -14.0 million USD | 1.4 million USD |
| 2015Q2 | -5.6 million USD | 1.4 million USD |
| 2015Q1 | -10.2 million USD | 1.4 million USD |
| 2014Q4 | -3.8 million USD | 1.4 million USD |
| 2014Q3 | -9.8 million USD | 6.5 million USD |
| 2013Q4 | -7.5 million USD | 11.1 million USD |
BGNE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -881.7 million USD | 2.5 billion USD |
| 2022 | -2.0 billion USD | 1.4 billion USD |
| 2021 | -1.4 billion USD | 1.2 billion USD |
| 2020 | -1.6 billion USD | 308.9 million USD |
| 2019 | -950.6 million USD | 428.2 million USD |
| 2018 | -673.8 million USD | 198.2 million USD |
| 2017 | -93.1 million USD | 238.4 million USD |
| 2016 | -119.2 million USD | 1.1 million USD |
| 2015 | -57.1 million USD | 8.8 million USD |
| 2014 | -18.3 million USD | 13.0 million USD |
| 2013 | -7.5 million USD | 11.1 million USD |
BGNE
Price: $153.58
52 week price:
Earnings Per Share: -8.45 USD
P/E Ratio: -16.01
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 346500
Ebitda: 116.2 millionMarket Capitalization: 15.1 billion